Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

53%

9 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
6(37.5%)
Phase 4
5(31.3%)
Phase 3
4(25.0%)
Phase 2
1(6.3%)
16Total
Phase 1(6)
Phase 4(5)
Phase 3(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT06490380Completed

HRD Status Reference Standard Based on WGS

Role: collaborator

NCT05694728Phase 2Completed

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Role: collaborator

NCT05680454Phase 1Completed

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Role: collaborator

NCT05662020Phase 3Active Not Recruiting

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Role: collaborator

NCT04091880Phase 4Completed

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine

Role: collaborator

NCT04559204Phase 4Completed

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Role: collaborator

NCT04054882Phase 4Completed

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP

Role: collaborator

NCT04638985Phase 4Unknown

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Role: collaborator

NCT04108845Phase 1Unknown

Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months

Role: collaborator

NCT01979900Phase 3Completed

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

Role: collaborator

NCT02964065Phase 3Completed

A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)

Role: collaborator

NCT02919293Phase 1Unknown

Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age

Role: collaborator

NCT02898922Phase 4Completed

Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C:An Open-label Control Study in China

Role: collaborator

NCT02878291Phase 1Unknown

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Role: collaborator

NCT02762045Phase 1Unknown

Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine

Role: collaborator

NCT02302170Phase 3Completed

A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children

Role: collaborator

NCT01881581Phase 1Unknown

Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS

Role: collaborator

All 17 trials loaded